Fleming

Biography

  World expert on diabetes; Co-Founder of Kinexum LLC – a leading strategic consulting organization in the cardiometabolic space. Serves on over a dozen clinical advisory boards for major pharmaceutical and biotech companies. FDA – 12 years, Head of Metabolic Group including diabetes, approved first statin, growth hormones, and all diabetes drugs in the 1990s. Represented FDA at international forums. Led professional education at CDER, FDA. CRO – 3 years Chief Scientific Officer, conducted drug trials worldwide, CRO sold to United Healthcare. Awarded his Doctorate of Medicine from Emory University, residency and fellowships at Vanderbilt University in endocrinology and NIH in metabolism

Research Interest

Pharmaceutical Science